Related Experiment Video
Updated: Jul 4, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
Overall and Disease Related Mortality in Parkinson's Disease - a Longitudinal Cohort Study
Jeroen Hoogland1, Bart Post2, Rob M A de Bie1
1Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Meibergdreef, AZ Amsterdam, The Netherlands.
Background:
Earlier research showed that Parkinson's disease is related to increased overall mortality, but it remains unclear which patient level factors are predictive of increased mortality in Parkinson's disease.
Objective:
To jointly evaluate potential risk factors for overall and Parkinson's disease (PD) related mortality, we collected detailed information from a cohort of newly diagnosed PD patients which was consequently followed for over a decade.
Methods:
A total of 133 consecutive patients with newly diagnosed PD were followed for at least 13 years. Survival analysis of observed mortality was used to evaluate risk factors for overall mortality, whereas survival analysis of mortality as corrected for the general population was used to evaluate risk factors for PD-related mortality.
Results:
Overall mortality increased with age, male sex, higher levodopa equivalent dose, and presence of mild cognitive impairment. PD-related mortality increased with earlier onset of Parkinson's disease, higher levodopa equivalent dose, and mild cognitive impairment.
Conclusions:
Our findings provide confirmation and extension of risk factors for overall mortality and generate new insights into PD-related mortality.
More Related Videos
10:28Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
Related Concept Videos
Longitudinal Research
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Alterations in Muscle Tone lll